No, I don't recall any public statements. I'm try
Post# of 148288
We were told it was a syringe issue. Clearly there were additional issues.
The fact that the fda has agreed with our "plan" tells me that we still have to execute said plan. The statement on the call the other day that we are waiting on the CRO tells me that they are analyzing something.
Id love to hear other theories. I believe they are trying to fix either the tropism, or the receptor occupancy. What else could it be?
Im not trying to be negative, I just don't take anything NP says at face value.